ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $698,000 | +13.9% | 19,300 | -8.5% | 0.00% | – |
| Q4 2020 | $613,000 | +1.0% | 21,100 | -1.9% | 0.00% | -100.0% |
| Q3 2020 | $607,000 | -9.8% | 21,500 | +3.4% | 0.00% | 0.0% |
| Q2 2020 | $673,000 | -22.6% | 20,800 | -2.6% | 0.00% | 0.0% |
| Q1 2020 | $870,000 | -72.1% | 21,359 | -57.8% | 0.00% | -66.7% |
| Q4 2019 | $3,123,000 | +117.0% | 50,637 | +156.5% | 0.00% | +200.0% |
| Q3 2019 | $1,439,000 | +3.7% | 19,740 | +17.0% | 0.00% | -50.0% |
| Q2 2019 | $1,387,000 | +17.2% | 16,871 | +0.6% | 0.00% | +100.0% |
| Q1 2019 | $1,183,000 | +56.7% | 16,771 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $755,000 | -24.8% | 16,771 | -5.6% | 0.00% | 0.0% |
| Q3 2018 | $1,004,000 | -22.4% | 17,765 | -8.2% | 0.00% | -50.0% |
| Q2 2018 | $1,293,000 | +20.1% | 19,354 | +4.6% | 0.00% | 0.0% |
| Q1 2018 | $1,077,000 | -5.6% | 18,503 | +4.5% | 0.00% | 0.0% |
| Q4 2017 | $1,141,000 | +22.8% | 17,700 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $929,000 | +12.2% | 17,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $828,000 | -24.7% | 17,700 | -20.3% | 0.00% | -50.0% |
| Q1 2017 | $1,099,000 | -2.0% | 22,200 | +20.0% | 0.00% | 0.0% |
| Q4 2016 | $1,121,000 | -38.1% | 18,500 | -32.2% | 0.00% | -33.3% |
| Q3 2016 | $1,811,000 | +15.1% | 27,300 | -3.2% | 0.00% | 0.0% |
| Q2 2016 | $1,574,000 | +114.4% | 28,200 | +29.4% | 0.00% | +200.0% |
| Q1 2016 | $734,000 | -29.9% | 21,800 | -6.0% | 0.00% | -50.0% |
| Q4 2015 | $1,047,000 | -36.0% | 23,200 | -44.0% | 0.00% | -33.3% |
| Q3 2015 | $1,636,000 | -42.9% | 41,400 | -10.4% | 0.00% | -25.0% |
| Q2 2015 | $2,866,000 | +30.6% | 46,189 | +13.0% | 0.00% | +33.3% |
| Q1 2015 | $2,195,000 | 0.0% | 40,889 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,195,000 | +223.7% | 40,889 | +70.4% | 0.00% | +200.0% |
| Q3 2014 | $678,000 | -17.9% | 23,989 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $826,000 | +760.4% | 23,989 | +329.2% | 0.00% | – |
| Q4 2013 | $96,000 | +74.5% | 5,589 | 0.0% | 0.00% | – |
| Q3 2013 | $55,000 | – | 5,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |